Back to REGN
MACKENZIE FINANCIAL CORP → REGN
MACKENZIE FINANCIAL CORP REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$96.9M
Q3 2026
Peak value
$96.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $72.3M |
| Q4 2025 | $60.8M |
| Q1 2026 | $66.7M |
| Q2 2026 | $84.7M |
| Q3 2026 | $96.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $96.9M | 127.8K | — | — |
| Q2 2026 | $84.7M | 135.8K | — | — |
| Q1 2026 | $66.7M | 86.3K | — | — |
| Q4 2025 | $60.8M | 78.7K | — | — |
| Q3 2025 | $72.3M | 128.6K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B